Catheter Precision (VTAK) announced registration and approval in the United Kingdom for its LockeT product, a suture retention device. LockeT received CE Mark for European approval and distribution in May 2025. Obtaining registration was the final approval required to launch sales in the UK. Catheter Precision has partnered with HC21, a UK-based value-added distributor for several years with a different product line and has entered into an additional agreement to distribute LockeT.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Implements 1-for-19 Reverse Stock Split
- Catheter Precision announces effectiveness of 1-for-19 reverse stock split
- Catheter Precision announces first LockeT cases completed in Germany
- Catheter Precision reports Q2 revenue $212,000 vs. $93,000 last year
- Upcoming Stock Splits This Week (August 11 to August 15) – Stay Invested